ERIM
TMO icon

Eagle Ridge Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Eagle Ridge Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$760K Buy
1,460
+34
+2% +$18.7K 0.07% 82
2024
Q3 		$882K Buy
1,426
+7
+0.5% +$4.14K 0.08% 75
2024
Q2 		$785K Buy
1,419
+170
+14% +$97.4K 0.07% 78
2024
Q1 		$726K Buy
1,249
+352
+39% +$198K 0.07% 83
2023
Q4 		$476K Sell
897
-309
-26% -$150K 0.05% 102
2023
Q3 		$610K Sell
1,206
-26
-2% -$13.9K 0.07% 89
2023
Q2 		$643K Buy
1,232
+14
+1% +$7.55K 0.07% 90
2023
Q1 		$702K Sell
1,218
-95
-7% -$53.5K 0.08% 85
2022
Q4 		$723K Buy
1,313
+31
+2% +$16.4K 0.08% 87
2022
Q3 		$650K Hold
1,282
– – 0.08% 87
2022
Q2 		$696K Buy
1,282
+264
+26% +$145K 0.08% 85
2022
Q1 		$601K Buy
1,018
+272
+36% +$156K 0.06% 94
2021
Q4 		$498K Buy
+746
New +$466K 0.05% 109
2020
Q4 		– Sell
-700
Closed -$309K – 143
2020
Q3 		$309K Hold
700
– – 0.04% 113
2020
Q2 		$254K Buy
+700
New +$235K 0.04% 111
2020
Q1 		– Sell
-722
Closed -$235K – 151
2019
Q4 		$235K Hold
722
– – 0.03% 145
2019
Q3 		$210K Hold
722
– – 0.03% 144
2019
Q2 		$212K Buy
+722
New +$199K 0.03% 147

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Ridge Investment Management's TMO Position: Q4 2024 in Review

Eagle Ridge Investment Management increased its Thermo Fisher Scientific (TMO) stake by 2.4% in Q4 2024, buying an estimated $18.7K and bringing the position to 1,460 shares worth $760K. The position accounts for 0.07% of the portfolio, ranked #82.

Eagle Ridge Investment Management first reported a position in TMO in Q2 2019 and has held it in 18 quarters since. The position peaked at $882K in Q3 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Eagle Ridge Investment Management held 1,460 shares of Thermo Fisher Scientific worth $760K as of Q4 2024.
  • Eagle Ridge Investment Management bought 34 Thermo Fisher Scientific shares in Q4 2024, an estimated $18.7K.
  • Thermo Fisher Scientific made up 0.07% of Eagle Ridge Investment Management's portfolio in Q4 2024, its #82 holding.
  • Eagle Ridge Investment Management first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 18 quarters since.
  • Eagle Ridge Investment Management's Thermo Fisher Scientific position peaked at $882K in Q3 2024.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Eagle Ridge Investment Management's 13F filing for Q4 2024, filed 27 Jan 2025.